MoonLake Immunotherapeutics (MLTX)
14.07
-0.54
(-3.70%)
USD |
NASDAQ |
Dec 11, 16:00
14.06
-0.02
(-0.11%)
After-Hours: 20:00
MoonLake Immunotherapeutics Shareholders Equity (Quarterly): 288.91M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Baxter International, Inc. | 7.241B |
| aTyr Pharma, Inc. | 80.24M |
| BeOne Medicines Ltd. | 4.129B |
| Merus NV | 774.93M |
| AC Immune SA | 78.48M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 414.34M |
| Total Liabilities (Quarterly) | 123.14M |
| Debt to Equity Ratio | 0.2621 |
| Current Ratio | 8.502 |
| Net Debt Paydown Yield | -3.17% |